Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers

NCT01389466 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

346

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Step 1
BIOLOGICAL: Step 2

Sponsor

Green Cross Corporation

Collaborators

[object Object]